AGNC Investment Corp (AGNC) Stock Price Today
Aura AI Summary
Key Stats
- $12.97BMarket Cap
- -Volume
- FinancialsSector
- $12.1752W High
- $9.6952W Low
- -Typical Hold Time
- -Enterprise Value
- 13.16%Div Yield
- -Trading Activity
Track AGNC Investment Corp (AGNC) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AGNC Investment Corp has traded between a low of $9.69 and a high of $12.17, highlighting its annual price range. Buy and sell AGNC Investment Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About AGNC Investment Corp
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage or real estate markets.
Most Recent News
Datadog CEO sells 47,054 shares worth $11.1M in a major stock transaction
Datadog CEO Olivier Pomel sold 47,054 shares of the company's stock, totaling $11.1 million. This significant sale could indicate personal financial planning or portfolio rebalancing. Investors may watch for any further insider transactions or compan...
Nexa Resources acquisition by Boliden faces legal review over board's shareholder duties.
Boliden AB plans to acquire Nexa Resources S.A. for $1.3 billion, boosting Nexa's stock target to $15.00 by Scotiabank, signaling a 10.38% potential gain. However, the deal is under legal scrutiny by Halper Sadeh LLC, which is investigating whether N...
Alnylam stock plunges after cutting 2026 sales forecast and facing legal probe.
Alnylam Pharmaceuticals saw its stock drop sharply after it lowered its 2026 sales guidance by about $200 million due to slower demand for its TTR products. Despite a strong biotech sector, Alnylam's shares fell by $81.14 per share, losing about 25% ...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.